Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

US NIH scientists discover ACDC, exploring bisphosphonates as treatment

This article was originally published in Scrip

Executive Summary

After 18 months endeavour, scientists at the US National Institutes of Health (NIH) have discovered ACDC. No, not the Australian "Highway to Hell" rock band, founded in the 1970s by the brothers Young, Angus and Malcolm. Nor does the finding involve alternating current/direct current, or electricity in any way. Instead, the NIH's breakthrough entails a rare genetic disease, which the agency has dubbed arterial calcification due to CD73 deficiency – ACDC – whose cause had previously not been identified.

Topics

Related Companies

Latest Headlines
See All
UsernamePublicRestriction

Register

SC011736

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel